Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label phase IV study of Gardasil in Japanese women aged 16 to 26 years
2015-002932-42Phase 4
- Sponsor
- MSD
- Start
- Dec 2016
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of qHPV vaccine in human papillomavirus infection, sponsored by MSD. Primary endpoint: Incidence of HPV 6-, 11-, 16- or 18-related CIN 2/3 or worse.
02
Drugs
qHPV vaccine
03
Conditions
human papillomavirus infection
Beyond the preview
Go deeper on 2015-002932-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-002932-42.